Cite

HARVARD Citation

    Friedman, C. et al. (2020). Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record